Stephen J. Kent spends much of his time researching Immunology, Virology, Antibody, Virus and Antigen. Stephen J. Kent combines topics linked to Cytotoxic T cell with his work on Immunology. His work carried out in the field of Virology brings together such families of science as Acquired immune system, Cellular immunity and DNA vaccination.
His research in Antibody intersects with topics in CD16 and Molecular biology. The study incorporates disciplines such as Pandemic and DNA virus in addition to Virus. Stephen J. Kent usually deals with Antigen and limits it to topics linked to T cell and Cell biology and Cytokine.
His primary areas of study are Immunology, Virology, Antibody, Immune system and Virus. His Antibody-dependent cell-mediated cytotoxicity, Immunity, Antigen, Vaccination and T cell investigations are all subjects of Immunology research. The concepts of his Antibody-dependent cell-mediated cytotoxicity study are interwoven with issues in Interleukin 21 and Fc receptor.
His work is dedicated to discovering how Virology, Cytotoxic T cell are connected with CD8 and other disciplines. Much of his study explores Antibody relationship to Receptor. His biological study spans a wide range of topics, including Cell, Disease and Cytokine.
Immunology, Antibody, Immune system, Immunity and Antigen are his primary areas of study. His Immunology research is multidisciplinary, incorporating elements of Pandemic, Disease and Coronavirus. His study in Antibody is interdisciplinary in nature, drawing from both Receptor and Virology.
His Virology research is multidisciplinary, relying on both Immunodominance, Monoclonal antibody and Immunogenicity. His studies deal with areas such as Convalescence and Lymph node as well as Immune system. Stephen J. Kent interconnects Cellular immunity and Mucosal associated invariant T cell in the investigation of issues within Immunity.
Stephen J. Kent mainly investigates Immunology, Antibody, Immunity, Vaccination and Immune system. His Immunology research is multidisciplinary, incorporating perspectives in Pandemic and Severe acute respiratory syndrome coronavirus 2. His Antibody research includes themes of Virus and Coronavirus.
His study with Virus involves better knowledge in Virology. In Immunity, Stephen J. Kent works on issues like T cell, which are connected to Cell, Priming and Human leukocyte antigen. His Immune system study incorporates themes from Transmission, Viral infectious disease, Disease and Mycobacterium tuberculosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
David S. Khoury;Deborah Cromer;Arnold Reynaldi;Timothy E. Schlub;Timothy E. Schlub.
Nature Medicine (2021)
Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation
Laura K. Mackay;Angus T. Stock;Joel Z. Ma;Claerwen M. Jones.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus
Stephen J. Kent;Anne Zhao;Susan J. Best;Jenalle D. Chandler.
Journal of Virology (1998)
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.
Wen Shi Lee;Adam K Wheatley;Stephen J Kent;Stephen J Kent;Brandon J DeKosky.
Nature microbiology (2020)
Minimum information reporting in bio-nano experimental literature.
Matthew Faria;Mattias Björnmalm;Kristofer J. Thurecht;Stephen J. Kent.
Nature Nanotechnology (2018)
Tuberculous Meningitis: A 30-Year Review
Kent Sj;Crowe Sm;Yung A;Lucas Cr.
Clinical Infectious Diseases (1993)
Photometric Redshifts for the SDSS Early Data Release
Istvan Csabai;Tamas Budavari;Andrew J. Connolly;Alexander S. Szalay.
arXiv: Astrophysics (2002)
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.
Jennifer A. Juno;Hyon Xhi Tan;Wen Shi Lee;Arnold Reynaldi.
Nature Medicine (2020)
Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies
Sinthujan Jegaskanda;Emma R. Job;Marit Kramski;Karen Laurie.
Journal of Immunology (2013)
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.
Adam K Wheatley;Jennifer A Juno;Jing J Wang;Kevin J Selva.
Nature Communications (2021)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: